• Ying Chen
  • Lan Sun
  • Guan-Hua DuEmail author


Cardiac glycosides, including digoxin, digitoxin, and lanatoside digitalis glycosides, are mainly isolated from lanatoside digitalis. They are used in the treatment of chronic congestive heart failure (CHF) and can also be used to treat some arrhythmia, and they show incomparable advantages in clinical practice. Cardiac glycosides have been used in clinical practice for more than two centuries, which is enough to prove its value. Because they are important agents in the treatment of CHF, the issues of narrow dose span and high-risk poisoning make it a meaningful task to find safer cardiac glycosides. Another important topic for future research is the effect of cardiac glycosides on the treatment of other diseases.


Cardiac glycosides Digitalis Digoxin Digitoxin Cedilanid 


  1. 1.
    Wilkins RM, Kendall JM, Wade LO. William Withering and digitalis, 1785 to 1985. Br Med J. 1985;290(6461):7–8.CrossRefGoogle Scholar
  2. 2.
    Lüderitz B. Cardiac glycosides: William Withering (1741–1799). J Interv Card Electrophysiol. 2005;14(1):61–2.CrossRefGoogle Scholar
  3. 3.
    Hui N. The story of the digitalis. Med People. 2001;5:38.Google Scholar
  4. 4.
    Congratulations on the Chinese academy of sciences institute of medicine for successfully extraction digitoxin. Chin Pharm J. 1954.Google Scholar
  5. 5.
    Yumen J, Wang X, Yang C, et al. Research progress on pharmacokinetics of cardiac glycosides. Chin Tradit Herb Drug. 2014;45(23):3472–7.Google Scholar
  6. 6.
    Calderónmontaño JM, Burgosmorón E, Orta ML, et al. Evaluating the cancer therapeutic potential of cardiac glycosides. Biomed Res Int. 2014;2014(12):85–117.Google Scholar
  7. 7.
    Yang S. Pharmacology. 2nd ed. Beijing: People’s Medical Publishing House; 2010. p. 234–8.Google Scholar
  8. 8.
    Shen B. Application of cardiac glycoside: experience for the treatment of 128 cases of heart failure. J Pract Med Tech. 2008;15(1):61–2.Google Scholar
  9. 9.
    Wei YU. Highlights of 2014. Guidelines for diagnosis and treatment of heart failure in China. Chin Clin Dr. 2015;(5):12–14.Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China 2018

Authors and Affiliations

  1. 1.Beijing Key Laboratory of Drug Target Identification and Drug ScreeningCentre for Pharmaceutical Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina

Personalised recommendations